Polypharmacy priorities — DGM MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Shared decision-making medicines review focused on goals and benefit horizon
In multimorbidity and frailty, medicines review should align treatment with goals, harms, benefit horizon and patient priorities. Stopping everything abruptly is unsafe, rigid single-disease prescribing increases burden, adding medicines first worsens polypharmacy, and larger boxes do not solve appropriateness. Good prescribing in geriatrics includes deprescribing and prioritisation.
Reference: NICE NG56; STOPP/START criteria v3